
Recent Articles
Relative Strength Shows Why the Bulls Are Right About Nikola Stock
By
Nicolas Chahine, InvestorPlace Contributor
Nikola stock has defied the odds because it has fans on Wall Street even before having any sales. The thesis has legs and for years.
Change the Exxon Mobil Stock Strategy to Suit the New Normal
By
Nicolas Chahine, InvestorPlace Contributor
The thesis to invest in Exxon Mobil stock has changed for ever. It now makes for a better dividend investment than a stock upside trade.
Confidence Is Essential for Novavax Stock Investors
By
Nicolas Chahine, InvestorPlace Contributor
NVAX stock is a binary trade because they are trying to make sure this time is different. Novavax can be a risky trade, but profitable.
Get on Board JetBlue Stock for a Complete Recovery Rally
By
Nicolas Chahine, InvestorPlace Contributor
JBLU stock has just survived the worst test ever so it's ready to recover. The downside risk from here is smaller than the upside opportunity.
How to Profit From Red-Hot Adobe Stock Before Earnings
By
Nicolas Chahine, InvestorPlace Contributor
Bulls are in control of Adobe, but uncertainty looms thanks to its upcoming earnings report. Here's how to profit from ADBE stock right now.
3 Hot Stocks to Buy on the Dip
By
Nicolas Chahine, InvestorPlace Contributor
Not all hot stocks are created equal, and most of the frothy ones are a no-touch. However, these three are the ones to buy on the dip.
How to Profit From the Momentum Behind UnitedHealth Stock
By
Nicolas Chahine, InvestorPlace Contributor
UnitedHealth is benefiting thanks to the coronavirus' impact on healthcare. Here is how to approach UNH stock at all-time highs.
The Bulls Are in Charge of Fastly Stock and It Still Has Room To Run
By
Nicolas Chahine, InvestorPlace Contributor
Fastly is well set to profit from the digital revolution post Covid-19, so FSLY stock is a BUY for the long term and on the looming breakout.
Twilio Stock Is a Rocks Star and May Not Be Done Yet
By
Nicolas Chahine, InvestorPlace Contributor
Twilio stock has enjoyed a 300% rally off the March lows. It earned a rest, so it's best to be cautious chasing too late into this rally.
Sorrento Therapeutics Stock Is Down but Not Out
By
Nicolas Chahine, InvestorPlace Contributor
SRNE stock is 60% off its highs, but such is the nature of these stocks. They are always one headline away from greatness.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.